Subject to change.
Subject to change.
David Chain is a Director of Translational Proteomics within AstraZeneca's Oncology R&D, Clinical Biomarker Development in Gaithersburg, MD. He holds a Ph.D. in Biomedical Informatics from Rutgers University and graduated from Rutgers College of Pharmacy. In his current role, David serves as a Team Lead, providing scientific leadership in the implementation of pathology-guided AI-based digital imaging modalities and lab automation initiatives for mass spectrometry-based cell enrichment.